Press releases
- Immunovia streamlines lab operations with move to Research Triangle Park, North Carolina
- Immunovia publishes the annual report for 2023
- Immunovia Publishes Interim Report for January-March 2024
- Invitation to Immunovia's Q1 presentation
- Immunovia announces updated financial calendar
- Immunovia announces positive results from the model-development study for its next-generation pancreatic cancer detection test
- Immunovia successfully develops assays to measure targeted proteins for its next-generation pancreatic cancer test - moving forward towards model-development study
- Immunovia Publishes Full Year Report for 2023
- Invitation to Immunovia's Q4 presentation
More ▼
Key statistics
As of last trade Immunovia AB (publ) (1YR:DEU) traded at 0.189, -48.50% below its 52-week high of 0.367, set on Nov 09, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 0.2005 |
---|---|
High | 0.201 |
Low | 0.165 |
Bid | 0.1478 |
Offer | 0.231 |
Previous close | 0.201 |
Average volume | 0.00 |
---|---|
Shares outstanding | 45.29m |
Free float | 34.20m |
P/E (TTM) | -- |
Market cap | 92.77m SEK |
EPS (TTM) | -6.06 SEK |
Data delayed at least 15 minutes, as of Apr 30 2024.
More ▼